ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,510.46
0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) News

ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZIVO
DateTimeSourceHeadlineSymbolCompany
27/04/202403:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202422:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202422:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
10/04/202401:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/03/202400:16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
16/02/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
16/02/202400:54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
08/02/202408:54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
30/01/202400:00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
23/01/202409:15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
18/01/202408:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
06/01/202409:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
05/01/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
04/01/202409:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
03/01/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
28/11/202301:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
23/11/202308:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
14/11/202308:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
04/11/202301:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
31/10/202304:20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202323:30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202323:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
26/10/202323:30Business WireZIVO Bioscience Announces Reverse Stock SplitNASDAQ:ZIVOZivo Bioscience Inc
05/10/202308:08Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ZIVOZivo Bioscience Inc
03/10/202323:30GlobeNewswire Inc.ZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
21/09/202323:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
20/09/202306:15Business WireTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
17/08/202305:00Business WireZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsNASDAQ:ZIVOZivo Bioscience Inc
15/08/202306:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
10/08/202306:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:ZIVO

Your Recent History

ASX
WES
Wesfarmers
ASX
CBA
Commonwealth Bank Of Aus...
ASX
XMM
S&P ASX 300 Metals and M...
ASX
WDC
Westfield
NASDAQ
AAPL
Apple
ASX
XTO
S&P ASX 100
ASX
XAO
Australian SE All Ordina...
NYSE
DIS
Walt Disney
ASX
QBE
QBE Insurance
ASX
WBC
Westpac Banking
ASX
MQG
Macquarie
ASX
WPL
Woodside Petroleum
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved